Detalhe da pesquisa
1.
Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial.
Gastric Cancer
; 25(1): 197-206, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34468869
2.
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial.
Lancet
; 392(10142): 123-133, 2018 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29880231
3.
Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design.
Future Oncol
; 15(6): 567-577, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30379568
4.
MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis.
J Surg Oncol
; 117(8): 1679-1686, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29790169
5.
Evolution of predictive and prognostic biomarkers in the treatment of advanced gastric cancer.
J Cancer Res Clin Oncol
; 148(8): 2023-2043, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35551464
6.
Evaluation of pembrolizumab monotherapy in patients with previously treated advanced salivary gland carcinoma in the phase 2 KEYNOTE-158 study.
Eur J Cancer
; 171: 259-268, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35777186
7.
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.
Lancet
; 376(9742): 687-97, 2010 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-20728210
8.
Phase II study of sunitinib as second-line treatment for advanced gastric cancer.
Invest New Drugs
; 29(6): 1449-58, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20461441
9.
Safety and Antitumor Activity of α-PD-L1 Antibody as Monotherapy or in Combination with α-TIM-3 Antibody in Patients with Microsatellite Instability-High/Mismatch Repair-Deficient Tumors.
Clin Cancer Res
; 27(23): 6393-6404, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34465599
10.
A phase I/II and pharmacogenomic study of pemetrexed and cisplatin in patients with unresectable, advanced gastric carcinoma.
Anticancer Drugs
; 21(8): 777-84, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20634689
11.
Efficacy and Safety of Ixabepilone and Capecitabine in Patients With Advanced Triple-negative Breast Cancer: a Pooled Analysis From Two Large Phase III, Randomized Clinical Trials.
Clin Breast Cancer
; 18(6): 489-497, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30153978
12.
Alteration of hTERT full-length variant expression level showed different gene expression profiles and genomic copy number changes in breast cancer.
Oncol Rep
; 15(4): 749-55, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16525654
13.
Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III Trial.
J Clin Oncol
; 34(5): 443-51, 2016 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26628478
14.
Infusional fluorouracil, etoposide, and cisplatin (FEP) in advanced and relapsed gastric cancer.
Am J Clin Oncol
; 26(2): 203-9, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12714898
15.
Sunitinib in metastatic renal cell carcinoma: an ethnic Asian subpopulation analysis for safety and efficacy.
Asia Pac J Clin Oncol
; 10(3): 237-45, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24576311
16.
Atypical reversible posterior leukoencephalopathy syndrome in a chronic haemodialysis patient with severe hypertension.
Nephrology (Carlton)
; 13(6): 542-3, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19138210
17.
Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group.
J Clin Oncol
; 30(27): 3361-7, 2012 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22915658
18.
Biweekly gemcitabine-paclitaxel, gemcitabine-carboplatin, or gemcitabine-cisplatin as first-line treatment in metastatic breast cancer after anthracycline failure: a phase II randomized selection trial.
Breast Cancer
; 18(3): 203-12, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21465229